Home
Markus Warmuth, President & CEO: Monte Rosa Therapeutics GLUE Sell · Filed 06/02
Trade details
- Type
- Insider sale
- Amount
- $97,011.18
- Shares · price
- 4,998 sh · $19.41 a share
- Held after
- 595,006 sh
- Trade date
- 26/06/01
- Filed
- 26/06/02
- Days to filing
- 1 days
Sold 0.8% of holdings
- Share of holding sold
- 0.8%
Monte Rosa Therapeutics trades, last 26 weeks
What else happened in Monte Rosa Therapeutics around then
Filed or reported within 30 days of the trade day · 05/02~07/01Markus Warmuth's recent trades
- Markus Warmuth
Planned saleMonte Rosa Therapeutics
Planned saleMonte Rosa Therapeutics
GLUE
$220.2K
9,500 sh
$220.2K
Filed 07/16
Traded 07/16
- Markus Warmuth
Sell10b5-1 planMonte Rosa Therapeutics
Sell10b5-1 planMonte Rosa Therapeutics
GLUE
$9,234
468 sh
$9,234
Filed 06/02
Traded 06/01
- Markus Warmuth
Planned sale10b5-1 planMonte Rosa Therapeutics
Planned sale10b5-1 planMonte Rosa Therapeutics
GLUE
$106.3K
5,466 sh
$106.3K
Filed 06/01
Traded 06/01
- Markus Warmuth
Sell10b5-1 planMonte Rosa Therapeutics
Sell10b5-1 planMonte Rosa Therapeutics
GLUE
$103.4K
5,467 sh
$103.4K
Filed 05/05
Traded 05/01
- Markus Warmuth
Planned sale10b5-1 planMonte Rosa Therapeutics
Planned sale10b5-1 planMonte Rosa Therapeutics
GLUE
$103.4M
5,467 sh
$103.4M
Filed 05/01
Traded 05/01